• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA高甲基化:当肿瘤抑制基因沉默时。

DNA hypermethylation: when tumour suppressor genes go silent.

作者信息

Garinis George A, Patrinos George P, Spanakis Nick E, Menounos Panayiotis G

机构信息

Laboratory of Reasearch, Nursing Military Academy, Athens, Greece.

出版信息

Hum Genet. 2002 Aug;111(2):115-27. doi: 10.1007/s00439-002-0783-6. Epub 2002 Jul 16.

DOI:10.1007/s00439-002-0783-6
PMID:12189484
Abstract

The phenotype of the cancerous cell may arise either from genetic alterations that disrupt gene function through sequence modifications (mutations) or epigenetic events that may alter the heritable state of gene expression (i.e. without changing the actual sequence of the genome). Whereas mutations in certain tumour suppressor genes are most often thought of in association with their inactivation during cancer initiation or progression, epigenetic alterations such as DNA methylation appear to be tightly linked to the sequential non-reversible events of normal tissue differentiation and organogenesis. This highlights a link between tissue differentiation and tumourigenesis with respect to the stable nature of certain epigenetic changes. In the case of tumourigenesis, both genetic and epigenetic mechanisms of altered gene expression often go hand in hand; not surprisingly, biallelic inactivation of a given tumour suppressor gene may occur via a combination of mutational and epigenetic events and is entirely consistent with the Knudson two-hit hypothesis of tumourigenesis. This review summarizes recent developments within the field of DNA methylation, highlighting its association with the transcriptional silencing of tumour suppressor genes in a variety of human cancers.

摘要

癌细胞的表型可能源于通过序列修饰(突变)破坏基因功能的基因改变,或者源于可能改变基因表达的可遗传状态(即不改变基因组的实际序列)的表观遗传事件。虽然某些肿瘤抑制基因的突变通常被认为与其在癌症发生或发展过程中的失活有关,但诸如DNA甲基化等表观遗传改变似乎与正常组织分化和器官发生的顺序不可逆事件紧密相连。这凸显了在某些表观遗传变化的稳定性方面,组织分化与肿瘤发生之间的联系。在肿瘤发生的情况下,基因表达改变的遗传和表观遗传机制往往同时出现;不足为奇的是,给定肿瘤抑制基因的双等位基因失活可能通过突变和表观遗传事件的组合发生,这与肿瘤发生的Knudson双击假说完全一致。本综述总结了DNA甲基化领域的最新进展,强调了其与多种人类癌症中肿瘤抑制基因转录沉默的关联。

相似文献

1
DNA hypermethylation: when tumour suppressor genes go silent.DNA高甲基化:当肿瘤抑制基因沉默时。
Hum Genet. 2002 Aug;111(2):115-27. doi: 10.1007/s00439-002-0783-6. Epub 2002 Jul 16.
2
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.CpG岛高甲基化与肿瘤抑制基因:蓬勃的现在,更光明的未来。
Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600.
3
Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.人类癌症中候选3p21.3抑癌基因BLU的表观遗传失活
Oncogene. 2003 Mar 13;22(10):1580-8. doi: 10.1038/sj.onc.1206243.
4
DNA methylation and gene silencing in cancer: which is the guilty party?癌症中的DNA甲基化与基因沉默:哪一方是罪魁祸首?
Oncogene. 2002 Aug 12;21(35):5380-7. doi: 10.1038/sj.onc.1205598.
5
[The roles of DNA methylation in human neoplasms].[DNA甲基化在人类肿瘤中的作用]
Ai Zheng. 2002 Nov;21(11):1267-77.
6
The role of DNA hypermethylation in human neoplasia.DNA高甲基化在人类肿瘤形成中的作用。
Electrophoresis. 2000 Jan;21(2):329-33. doi: 10.1002/(SICI)1522-2683(20000101)21:2<329::AID-ELPS329>3.0.CO;2-9.
7
Dormant hypermethylated tumour suppressor genes: questions and answers.沉默的高甲基化肿瘤抑制基因:问答
J Pathol. 2005 Jan;205(2):172-80. doi: 10.1002/path.1707.
8
Epigenetic changes in cancer and preneoplasia.癌症和癌前病变中的表观遗传变化。
Cold Spring Harb Symp Quant Biol. 2005;70:329-33. doi: 10.1101/sqb.2005.70.036.
9
DNA methylation differences associated with tumor tissues identified by genome scanning analysis.通过基因组扫描分析鉴定出的与肿瘤组织相关的DNA甲基化差异。
Genomics. 1998 Nov 1;53(3):260-8. doi: 10.1006/geno.1998.5502.
10
Gene silencing by DNA methylation in haematological malignancies.血液系统恶性肿瘤中DNA甲基化介导的基因沉默
Br J Haematol. 2007 Jul;138(1):3-11. doi: 10.1111/j.1365-2141.2007.06604.x. Epub 2007 May 9.

引用本文的文献

1
Promoter Methylation of HIV Coreceptor-Related Genes CCR5 and CXCR4: Original Research.HIV共受体相关基因CCR5和CXCR4的启动子甲基化:原始研究
Viruses. 2025 Mar 25;17(4):465. doi: 10.3390/v17040465.
2
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications.肝细胞癌中肿瘤异质性与免疫逃逸机制的关联及其临床意义。
Br J Cancer. 2024 Aug;131(3):420-429. doi: 10.1038/s41416-024-02684-w. Epub 2024 May 17.
3
Understanding Cancer's Defense against Topoisomerase-Active Drugs: A Comprehensive Review.
了解癌症对拓扑异构酶活性药物的防御机制:全面综述。
Cancers (Basel). 2024 Feb 6;16(4):680. doi: 10.3390/cancers16040680.
4
Role of Epigenetics for the Efficacy of Cisplatin.表观遗传学在顺铂疗效中的作用。
Int J Mol Sci. 2024 Jan 17;25(2):1130. doi: 10.3390/ijms25021130.
5
Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome.细胞周期蛋白依赖性激酶抑制剂2A的基因和表观遗传改变干扰多种免疫成分并预示不良临床结果。
Biomedicines. 2023 Aug 11;11(8):2254. doi: 10.3390/biomedicines11082254.
6
Haematological profile of malaria patients with G6PD and PKLR variants (erythrocytic enzymopathies): a cross-sectional study in Thailand.携带 G6PD 和 PKLR 变异(红细胞酶病)的疟疾患者的血液学特征:泰国的一项横断面研究。
Malar J. 2022 Aug 30;21(1):250. doi: 10.1186/s12936-022-04267-7.
7
NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation-mediated CCM1/2 expression.NOGOB 受体缺失通过损害组蛋白乙酰化介导的 CCM1/2 表达增加脑血管通透性和出血。
J Clin Invest. 2022 May 2;132(9). doi: 10.1172/JCI151382.
8
Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis.唾液DNA甲基化作为头颈癌的一种表观遗传生物标志物。第一部分:诊断准确性的荟萃分析。
J Pers Med. 2021 Jun 17;11(6):568. doi: 10.3390/jpm11060568.
9
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.雌激素受体β:转移中的有前途的生物标志物和潜在靶点。
Int J Mol Sci. 2021 Feb 6;22(4):1656. doi: 10.3390/ijms22041656.
10
Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.表观遗传微小RNA对人类癌症中DNA甲基化机制的调控:癌症治疗中新兴的新靶点
Cancer Gene Ther. 2021 Apr;28(3-4):157-174. doi: 10.1038/s41417-020-00210-7. Epub 2020 Aug 10.